PERRY MATTHEW D
Insider CIK 1454337 · XOMA Director · CTI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XOMA XOMA Royalty Corp | D To issuer deriv | 2026-07-14 | 2026-07-14 | 8,996 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | D To issuer deriv | 2026-07-14 | 2026-07-14 | 6,152 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | D To issuer deriv | 2026-07-14 | 2026-07-14 | 10,967 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | D To issuer deriv | 2026-07-14 | 2026-07-14 | 8,167 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | D To issuer deriv | 2026-07-14 | 2026-07-14 | 5,052 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | D To issuer deriv | 2026-07-14 | 2026-07-14 | 5,101 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | D To issuer deriv | 2026-07-14 | 2026-07-14 | 15,222 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | J Other | 2026-07-14 | 2026-07-14 | 24,138 | — | $0 | 0 | SEC↗ |
| XOMA XOMA Royalty Corp | A Award | 2026-05-21 | 2026-05-26 | 3,586 | — | $0 | 27,426 | SEC↗ |
| XOMA XOMA Royalty Corp | A Award | 2025-05-21 | 2025-05-23 | 5,971 | — | $0 | 23,840 | SEC↗ |
| XOMA XOMA Corp | A Award | 2024-05-15 | 2024-05-17 | 6,070 | — | $0 | 17,869 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 60,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 50,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 80,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 80,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 80,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | D To issuer deriv | 2023-06-26 | 2023-06-26 | 120,000 | — | $0 | 0 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | U Tender | 2023-06-26 | 2023-06-26 | 43,139 | $9.10 | $392.6K | 0 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2023-05-17 | 2023-05-19 | 10,967 | — | $0 | 10,967 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2023-04-05 | 2023-04-07 | 80,000 | — | $0 | 80,000 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2022-05-18 | 2022-05-20 | 8,996 | — | $0 | 8,996 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2022-03-09 | 2022-03-11 | 80,000 | — | $0 | 80,000 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2021-05-19 | 2021-05-21 | 5,101 | — | $0 | 5,101 | SEC↗ |
| CTIC CTI BIOPHARMA CORP | A Award deriv | 2021-03-10 | 2021-03-12 | 80,000 | — | $0 | 80,000 | SEC↗ |
| XOMA XOMA Corp | P Buy | 2020-12-11 | 2020-12-15 | 200,000 | $25.00 | $5.00M | 200,000 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2020-05-20 | 2020-05-27 | 6,152 | — | $0 | 6,152 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2019-05-16 | 2019-05-20 | 8,167 | — | $0 | 8,167 | SEC↗ |
| CTI CTI BIOPHARMA CORP | A Award deriv | 2019-05-16 | 2019-05-20 | 120,000 | — | $0 | 120,000 | SEC↗ |
| CTI CTI BIOPHARMA CORP | A Award deriv | 2018-05-17 | 2018-05-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2018-05-17 | 2018-05-21 | 5,052 | — | $0 | 5,052 | SEC↗ |
| CTI CTI BIOPHARMA CORP | M Exercise deriv | 2017-04-28 | 2017-05-02 | 34,736 | — | $0 | 0 | SEC↗ |
| CTI CTI BIOPHARMA CORP | M Exercise | 2017-04-28 | 2017-05-02 | 34,736 | — | $0 | 43,139 | SEC↗ |
| XOMA XOMA Corp | A Award deriv | 2017-03-02 | 2017-03-07 | 15,222 | — | $0 | 15,222 | SEC↗ |
| XOMA XOMA Corp | A Award | 2017-03-02 | 2017-03-07 | 11,799 | — | $0 | 11,799 | SEC↗ |
| CTI CTI BIOPHARMA CORP | A Award deriv | 2017-02-23 | 2017-02-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CTI CTI BIOPHARMA CORP | M Exercise deriv | 2017-01-11 | 2017-01-13 | 8,403 | — | $0 | 0 | SEC↗ |
| CTI CTI BIOPHARMA CORP | M Exercise | 2017-01-11 | 2017-01-13 | 8,403 | — | $0 | 8,403 | SEC↗ |
| CTI CTI BIOPHARMA CORP | A Award deriv | 2016-04-29 | 2016-05-03 | 347,360 | — | $0 | 431,394 | SEC↗ |
| CTI CTI BIOPHARMA CORP | A Award deriv | 2016-01-11 | 2016-01-13 | 84,034 | — | $0 | 84,034 | SEC↗ |